Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

[Application and value of mutation detection in diagnosis and treatment of gastrointestinal stromal tumor].

Cao H, Wang M.

Zhonghua Wei Chang Wai Ke Za Zhi. 2013 Mar;16(3):208-11. Chinese.

PMID:
23536336
2.

[Molecular and genetic features of gastrointestinal stromal tumors (GIST)].

Buleje S J, Yábar B A, Guevara-Fujita M, Fujita R.

Rev Gastroenterol Peru. 2012 Oct-Dec;32(4):394-9. Review. Spanish.

PMID:
23307090
3.

Clinicopathology and molecular diagnostics of gastrointestinal stromal tumors.

Lucas DR.

Curr Probl Cancer. 2011 Sep-Oct;35(5):233-44. doi: 10.1016/j.currproblcancer.2011.09.002. No abstract available.

PMID:
22118563
4.
5.

Gastrointestinal stromal tumor and its targeted therapeutics.

Dupart J, Zhang W, Trent JC.

Chin J Cancer. 2011 May;30(5):303-14. Review.

6.

Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours.

Lasota J, Miettinen M.

Histopathology. 2008 Sep;53(3):245-66. doi: 10.1111/j.1365-2559.2008.02977.x. Epub 2008 Feb 28. Review.

PMID:
18312355
7.
8.

Pathology of gastrointestinal stromal tumors.

Hirota S, Isozaki K.

Pathol Int. 2006 Jan;56(1):1-9. Review.

PMID:
16398673
9.

[Gastrointestinal stromal tumors (GIST): at the forefront of targeted therapies].

Emile JF.

Med Sci (Paris). 2013 Jun-Jul;29(6-7):630-6. doi: 10.1051/medsci/2013296016. Epub 2013 Jul 12. Review. French.

10.

c-kit and PDGFRA mutations in extragastrointestinal stromal tumor (gastrointestinal stromal tumor of the soft tissue).

Yamamoto H, Oda Y, Kawaguchi K, Nakamura N, Takahira T, Tamiya S, Saito T, Oshiro Y, Ohta M, Yao T, Tsuneyoshi M.

Am J Surg Pathol. 2004 Apr;28(4):479-88.

PMID:
15087667
11.

Molecular pathology of gastrointestinal stromal tumors and implications for treatment and prognosis.

Parkin B, Chugh R.

Curr Probl Cancer. 2011 Sep-Oct;35(5):245-54. doi: 10.1016/j.currproblcancer.2011.10.002. No abstract available.

PMID:
22118564
12.

An overview on molecular biology of KIT/PDGFRA wild type (WT) gastrointestinal stromal tumours (GIST).

Nannini M, Biasco G, Astolfi A, Pantaleo MA.

J Med Genet. 2013 Oct;50(10):653-61. doi: 10.1136/jmedgenet-2013-101695. Epub 2013 Jul 5. Review.

PMID:
23833252
13.

Results on prognostic value of mutations in localized gastrointestinal stromal tumors (GIST) in one single center.

Garcés-Albir M, Marti-Obiol R, López-Mozos F, Calabuig-Fariñas S, Navarro-Ros S, Ortega-Serrano J.

Rev Esp Enferm Dig. 2012 Aug;104(8):405-10.

14.

Low frequency of MAP kinase pathway alterations in KIT and PDGFRA wild-type GISTs.

Martinho O, Gouveia A, Viana-Pereira M, Silva P, Pimenta A, Reis RM, Lopes JM.

Histopathology. 2009 Jul;55(1):53-62. doi: 10.1111/j.1365-2559.2009.03323.x.

PMID:
19614767
15.

Gastrointestinal stromal tumors in children and young adults: a clinicopathologic and molecular genetic study of 22 Korean cases.

Kang G, Park YS, Jung ES, Joo M, Kang MS, Ahn S, Kang GH, Kim KM.

APMIS. 2013 Oct;121(10):938-44. doi: 10.1111/apm.12085. Epub 2013 Jun 12.

PMID:
23755839
16.

[c-Kit and PDGFRA mutations and clinico-morphological features of gastrointestinal stromal tumors].

Beliakov IS, Anurova OA, Snigur PV, Tsyganova IV, Sel'chuk VIu, Mazurenko NN.

Vopr Onkol. 2007;53(6):677-81. Russian.

PMID:
18416137
17.

Mutational profile of KIT and PDGFRA genes in gastrointestinal stromal tumors in Peruvian samples.

Buleje J, Acosta Ó, Guevara-Fujita M, Enriquez Y, Taxa L, Machicado E, Lizaraso-Caparó F, Fujita R.

Rev Esp Enferm Dig. 2015 Feb;107(2):72-8.

18.

Impressive long-term disease stabilization by nilotinib in two pretreated patients with KIT/PDGFRA wild-type metastatic gastrointestinal stromal tumours.

Pantaleo MA, Nannini M, Saponara M, Gnocchi C, Di Scioscio V, Lolli C, Catena F, Astolfi A, Di Battista M, Biasco G; GIST Study Group, University of Bologna, Bologna, Italy.

Anticancer Drugs. 2012 Jun;23(5):567-72. doi: 10.1097/CAD.0b013e328352cc50.

PMID:
22430048
19.

GEIS 2013 guidelines for gastrointestinal sarcomas (GIST).

Poveda A, del Muro XG, López-Guerrero JA, Martínez V, Romero I, Valverde C, Cubedo R, Martín-Broto J.

Cancer Chemother Pharmacol. 2014 Nov;74(5):883-98. doi: 10.1007/s00280-014-2547-0. Epub 2014 Sep 6. Review.

20.

[Gastrointestinal stromal tumors: a rare nosological entity and a model example for the use of personalized therapy with a molecular basis].

Bettegazzi C, Erra S.

Recenti Prog Med. 2015 Jan;106(1):52-7. doi: 10.1701/1740.18964. Italian.

PMID:
25621782

Supplemental Content

Support Center